account_balance
Investment manager · 13F filer · SEC CIK 1848809
Velan Capital Investment Management LP
Reported value$163Mas of Jun 30, 2026
Positions50 6 new, 5 sold out
Top 10 weight75.2%PRAX alone is 18%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
PRAXPraxis Precision Medicines I
18.2%Trimmed −12%
MPLTMaplight Therapeutics Inc
10.8%
STROSutro Biopharma Inc
10.4%
IMMXImmix Biopharma Inc
6.9%Added +47%
TARAProtara Therapeutics Inc
6.7%
ABVXAbivax SA
5.4%Trimmed −15%
TENXTenax Therapeutics Inc
4.9%Trimmed −6%
AVRAnteris Technologies Global
4.2%
EDSAEdesa Biotech Inc
4.1%
EVMNEvommune Inc
3.7%
AVTXAvalo Therapeutics Inc
3.7%Added +75%
XNCR2.5%PRAXPraxis Precision Medicines I
18.2%Trimmed −12%
MPLTMaplight Therapeutics Inc
10.8%
STRO10.4%IMMX6.9%TARAProtara Therapeutics Inc
6.7%
ABVX5.4%TENX4.9%AVR4.2%EDSA4.1%EVMN3.7%AVTX3.7%XNCR2.5%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
PRAX Praxis Precision Medicines I 18.2% Trimmed −12%MPLT Maplight Therapeutics Inc 10.8% HeldSTRO Sutro Biopharma Inc 10.4% HeldIMMX Immix Biopharma Inc 6.9% Added +47%TARA Protara Therapeutics Inc 6.7% HeldABVX Abivax SA 5.4% Trimmed −15%TENX Tenax Therapeutics Inc 4.9% Trimmed −6%AVR Anteris Technologies Global 4.2% HeldEDSA Edesa Biotech Inc 4.1% HeldEVMN Evommune Inc 3.7% HeldAVTX Avalo Therapeutics Inc 3.7% Added +75%XNCR Xencor Inc 2.5% Added +2%
What changed